When it comes to seeking the best oncologist in Vizag or even in India, Dr B Ravi Shankar stands out as a top choice. With a specialization in Clinical Oncology, he has established himself as one of the leading experts in the field. His expertise and dedication have earned him the reputation of bein

2 views • 6 slides

Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of canc

0 views • 5 slides

Epigenetics Market by Offering (Kits, Reagents, Instruments, Software) Method (DNA Methylation, PCR, Chromatin Analysis, Histone, RNA Modification), Application (Oncology, Non-oncology) End User (Pharma, Academics, Hospitals) \u2013 Global Forecast to 2030\n

0 views • 4 slides

In the field of oncology care, the importance of effective management to reduce burnout among healthcare providers is highlighted. Stress, psychosocial risks, and burnout definitions are explored, emphasizing the impact on healthcare professionals' well-being and job satisfaction. Studies reveal hig

2 views • 69 slides

Explore how the COVID-19 pandemic has spurred the adoption of telehealth in oncology, as discussed by Dr. Samantha Jaglowski from The Ohio State University. Discover the rationale, barriers, implementation strategies, and future directions for telehealth in cancer care.

3 views • 59 slides

The LABS.FOR.LIFE.PROJECT in India focuses on immunoassays using ELISA technology for measuring hormones, drugs, and serological markers. The project involves different formats of immunoassays like Sandwich, Competitive, Indirect, and Two-Step Immuno-capture. Various steps involved in immunoassays a

4 views • 34 slides

\n\nGemtuzumab 4.5 mg is a monoclonal antibody that targets CD33 antigen, which is found on the surface of leukemia cells. In precision oncology, this drug has been used to treat patients with acute myeloid leukemia (AML) who are deemed appropriate for this therapy. It has been shown to increase sur

1 views • 3 slides

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA would address the challenges and future directions in IO research. \n\nRegister Now @ \/\/events.marketsandmarkets.com\/immuno-on

1 views • 6 slides

Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg im Breisgau, Germany.\n\nRegister Now @ \/\/events.marketsandmarkets.com\/immunobio-series\/register

1 views • 6 slides

RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post Market Surveillance), End User (Pharma, Payer, Provider) - Global Forecast to 2029

1 views • 3 slides

This module provides training on medical terminology basics for patient navigators in oncology. It covers defining terms using prefixes, root words, and suffixes, common oncology words, and available resources. Learn how to approach medical terminology effectively by understanding word roots and com

1 views • 20 slides

Lujia Chen, a Postdoc Associate at the University of Pittsburgh, focuses on developing deep learning models for precision oncology. By utilizing machine learning, especially deep learning models, Chen aims to identify cancer signaling pathways, predict drug sensitivities, and personalize cancer trea

1 views • 5 slides

Providing an overview of patient navigation in oncology, this educational material covers social determinants of health, patient navigation history, core competencies, and models in the field. Supported by the CDC, it discusses disparities in healthcare access and the impact on medically underserved

2 views • 37 slides

This content delves into the essentials of patient navigation in oncology, covering competencies, professional roles, responsibilities, and functions of patient navigators. It highlights the importance of patient empowerment, communication, cultural competency, and care coordination. The material al

0 views • 43 slides

Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany.\n\nRegister Now @ \/\/events.marketsandmarkets.

1 views • 5 slides

This module delves into the fundamentals of health care navigation with a focus on oncology patients. It covers the core competencies for patient navigators, compares hospital structures, explores cancer care delivery methods, discusses inpatient and outpatient care, and highlights different types o

0 views • 32 slides

Integrative oncology blends conventional cancer treatments with mind-body practices, natural products, and lifestyle modifications to improve health, quality of life, and clinical outcomes. This approach empowers individuals to actively participate in their care journey, promoting overall well-being

0 views • 18 slides

This module focuses on Program Evaluation and Quality Improvement for Patient Navigators in oncology, covering competencies, learning objectives, definitions, and reasons for evaluation. It emphasizes the importance of evaluating programs to improve effectiveness, secure funding, meet accreditation

0 views • 39 slides

The concept of estimands in oncology clinical trials plays a crucial role in defining treatment effects and analyzing overall survival outcomes. This framework aims to enhance transparency, align trial objectives, and strengthen interdisciplinary dialogues. Introduced by the ICH E9(R1) guideline in

0 views • 14 slides

Explore the significance of social determinants of health and health disparities in the context of oncology patient navigation. Delve into the history, models, and core competencies of patient navigation while addressing the impact of medically underserved populations and cancer health disparities.

0 views • 37 slides

This educational curriculum emphasizes the importance of addressing psychiatric comorbidities in palliative care and psycho-oncology patients. It covers diagnostic challenges, evidence-based treatments, and screening for substance use disorders. The content also discusses the principles of palliativ

0 views • 53 slides

Understanding the significance of physical therapy in pediatric oncology, this resource emphasizes early screening and intervention to minimize long-term impairments for children with cancer. It covers identifying side effects of cancer treatment, typical motor development, the role of physical ther

0 views • 32 slides

Provide an overview of common Musculoskeletal (MSK) oncology pathology assessment, management principles, and preparation for FRCS. The agenda includes topics like soft tissue sarcomas, bone tumors, metastatic bone disease, vivas/cases, and guest speakers sharing valuable insights. Feedback is encou

0 views • 11 slides

This document contains contact information for various hospitals in the West Midlands offering acute oncology services, including details on advice lines, nurses, consultants, and specific cancer services. Stay informed about the hospitals in your area that provide specialist care for cancer patient

0 views • 17 slides

Explore the world of radiation therapy in oncology with insights on indications, side effects, case studies, and treatment protocols. Understand how radiation therapy works, its various types, planning procedures, dose prescription, and patient management. Delve into the essential aspects of local t

0 views • 46 slides

This document lists contact information for various hospitals in the West Midlands area related to acute oncology services, including details of 24-hour advice lines, oncology nurses, consultants, and specific cancer service leads. Updates and changes to the information should be notified via email

0 views • 17 slides

Neuro-Oncology Prehabilitation Service saw 73 new patients between Nov 2022-April 2023. Patients with high-grade gliomas, low-grade gliomas, and brain metastases received tailored interventions pre and post-surgery. Patient feedback was positive, indicating a very good overall experience. The servic

0 views • 5 slides

\"The Global Hemato Oncology Testing Market Size is expected to reach USD 9.4 Billion by 2032, at a CAGR of 8.13% during the forecast period 2022 to 2032. \n\n\"\n

1 views • 5 slides

Master protocols, seamless trials, and adaptive designs are revolutionizing oncology drug development. These innovative approaches involve multiple substudies with different objectives, evaluating investigational drugs across disease subtypes. Basket trials and umbrella trials offer flexibility in s

0 views • 13 slides

Explore the shifting trends in oncology drug development, from understanding cancer mechanisms to new immuno-oncology approaches. Delve into the role of statisticians in researching cancer drugs and uncover the importance of early-phase trials in validating treatment mechanisms. Discover the need fo

0 views • 22 slides

Explore the intricate details of cancer treatment through precision oncology, focusing on cell of origin, genomic changes, tumor microenvironment, host factors, and response to various treatments such as chemotherapy, biological therapy, and immune therapy. The natural history and histology-guided c

0 views • 9 slides

This collection highlights clinical and pathological staging cases in oncology, covering scenarios from colon, lung, bladder, and kidney cancer. Each case presents detailed information on tumor characteristics, lymph node involvement, metastasis status, and clinical stages. Images accompany the desc

0 views • 9 slides

Vicky Wilton, a Pediatric Interlink Nurse in Northern Ontario, presented on pediatric palliative care focusing on identifying differences and similarities between pediatric and adult care, integrating advance care planning, and emphasizing hope. The role of Pediatric Interlink Nurses within the Pedi

0 views • 69 slides

Patient feedback for the Neuro-Oncology services at Bristol Haematology Oncology Centre reflects a consistently positive experience. Patients found the staff to be supportive, informative, attentive, caring, and empathetic. The professionalism, humanism, kindness, and generosity of the oncology team

0 views • 9 slides

Bel Mondo Beauty introduces a breakthrough Moisture Renewal Mask made from bio cellulose, a fabric with incredible skin affinity and efficient ingredient transfer. This professional series mask targets oncology spa services, developed in collaboration with Oncology Spa Solutions to care for clients

0 views • 19 slides

Using KEYNOTE-024 as a case study, this presentation examines the impact of cut-point selection on long-term survival estimates from piecewise modeling in immuno-oncology therapies. It explores the uncertainty in IO survival extrapolations and the use of piecewise survival models as a flexible alter

0 views • 22 slides

Efficacy screening in oncology trials involves evaluating multiple tumor types simultaneously to enhance drug development efficiency. Basket trials minimize missed opportunities but risk cherry-picking for positive results. Statistical methods, like multiplicity control and Bayesian information borr

0 views • 19 slides

Comparison between sublobar resection and stereotactic ablative radiotherapy (SAbR) in high-risk patients with stage I non-small cell lung cancer has faced challenges like poor accrual, equipoise concerns among surgeons, and complex eligibility criteria. Traditional phase III trials struggle due to

0 views • 35 slides

Explore the application of Artificial Intelligence in Oral & Maxillofacial Oncology through a presentation prepared by Dr. Parul Khare Sinha, a renowned specialist in the field. The presentation delves into cutting-edge research, collaborations with top experts, and the use of machine learning for a

0 views • 25 slides

The field of oncology presents unique opportunities for advancing drug development through novel therapeutic modalities like immunotherapies, cell and gene therapies, and radioligand therapies. However, regulators, sponsors, and payers face criticism, often due to non-significant results in overall

0 views • 16 slides